https___www.spectrumhealth.org_services_cancer_blood-cancer_myeloma.xml
https___sorrentotherapeutics.com_ne_research_product-candidates_cd38-car-t-dar-t__1.xml
1.1 2.1 2.2 2.3 2.4 2.5 3.1 4.1 4.2 4.3 5.1 5.2 6.1 7.1 7.2 8.1 8.2 9.1
/ Myeloma Myeloma is a cancer that begins in plasma cells. Plasma cells are white blood cells that fight infection as part of the immune system. Abnormal, cancerous plasma cells are called myeloma cells. Myeloma cells can weaken the immune system, interfere with blood cell production, damage the kidneys and weaken bones. Because myeloma cells collect at many sites in the bone marrow, the disease is often referred to as “multiple myeloma.” Some people, including those who are male, or African-American, have higher risk factors for myeloma than others do. People with multiple myeloma often find out about their disease because of symptoms such as constipation, fatigue, frequent thirst and urination, muscle weakness or bone pain. Some people may not experience any symptoms. Multiple myeloma is often found during routine blood and urine tests. Spectrum Health has one of the most sophisticated diagnostic laboratories in the country—often allowing us to make a diagnosis in just a few hours to a few days. This is significantly faster than most cancer centers. Also called "watchful waiting," you can forego the side effects of treatment with careful monitoring of the stage of this cancer. This process delivers healthy blood or bone marrow (as stem cells) to replace unhealthy bone marrow. Before the transplant, intensive treatment will kill as many cancer cells as possible to set the stage for new bone marrow growth. This well-known cancer treatment uses medicines taken intravenously or by mouth to kill cancer cells throughout the body. Chemotherapy may be given before surgery to shrink tumors, or after to fight cancer cells that have potentially spread. If you have been diagnosed with cancer and would like a consultation or second opinion.
1.1 2.1 3.1 4.1 5.1 6.1 7.1 8.1 9.1
- दोस्रो सबैभन्दा सामान्य रक्त क्यान्सर - उपन्यास एजेन्टहरूको बढ्दो उपलब्धताको बावजुद, यो रोग पुनरावर्ती पुनरावृत्तिको ढाँचा द्वारा विशेषता हो र अधिकांश बिरामीहरूको लागि निको नहुने रहन्छ। - प्रति वर्ष लगभग 80,000 मृत्यु, विश्वव्यापी - 114,000 नयाँ केसहरू प्रति वर्ष विश्वव्यापी रूपमा निदान गरिएको छ - प्लाज्मा कोशिकाहरू हड्डी मज्जा मा सेतो रक्त कोशिका को एक प्रकार हो। यो अवस्था संग, प्लाज्मा कोशिकाहरु को एक समूह क्यान्सर र गुणा हुन्छ - यो रोगले हड्डी, प्रतिरक्षा प्रणाली, मृगौला र रातो रक्त कोशिकाको संख्यामा क्षति पुर्याउन सक्छ - उपचारमा औषधि, केमोथेरापी, कोर्टिकोस्टेरोइड्स, विकिरण, वा स्टेम सेल प्रत्यारोपण समावेश हुन्छ। - मानिसहरूले ढाड वा हड्डीमा दुखाइ, रक्तअल्पता, थकान, कब्जियत, हाइपरक्याल्सेमिया, मृगौला क्षति, वा तौल घट्ने अनुभव गर्न सक्छन्। क्यान्सर प्लाज्मा कोशिकाहरूले हड्डीलाई कमजोर बनाउँछ जसले फ्र्याक्चर गर्दछ